Maleki S, Hendrikse J, Richardson K, Segrave R, Hughes S, Kayayan E
Transl Psychiatry. 2024; 14(1):429.
PMID: 39389949
PMC: 11467328.
DOI: 10.1038/s41398-024-03150-0.
Wallace A, Huestis M, Sullivan R, Wade N
Behav Brain Res. 2024; 472:115150.
PMID: 39009188
PMC: 11656890.
DOI: 10.1016/j.bbr.2024.115150.
Soleimani N, Kazemi K, Helfroush M, Aarabi A
Sci Rep. 2023; 13(1):5847.
PMID: 37037859
PMC: 10086048.
DOI: 10.1038/s41598-023-32521-8.
Bedillion M, Blaine S, Claus E, Ansell E
Curr Behav Neurosci Rep. 2023; 8(4):134-149.
PMID: 36908333
PMC: 9997650.
DOI: 10.1007/s40473-021-00243-8.
Lotan A, Luza S, Opazo C, Ayton S, Lane D, Mancuso S
Mol Psychiatry. 2023; 28(5):2058-2070.
PMID: 36750734
PMC: 10575779.
DOI: 10.1038/s41380-023-01979-3.
Prefrontal cortex and putamen grey matter alterations in cannabis and tobacco users.
Daniju Y, Faulkner P, Brandt K, Allen P
J Psychopharmacol. 2022; 36(12):1315-1323.
PMID: 36112825
PMC: 9716493.
DOI: 10.1177/02698811221117523.
The Construct of Medical and Non-Medical Marijuana-Critical Review.
Silczuk A, Smulek D, Kolodziej M, Gujska J
Int J Environ Res Public Health. 2022; 19(5).
PMID: 35270462
PMC: 8910105.
DOI: 10.3390/ijerph19052769.
The Effects of Nicotine and Cannabis Co-Use During Late Adolescence on White Matter Fiber Tract Microstructure.
Courtney K, Sorg S, Baca R, Doran N, Jacobson A, Liu T
J Stud Alcohol Drugs. 2022; 83(2):287-295.
PMID: 35254252
PMC: 8909919.
Evidence That Cannabis Exposure, Abuse, and Dependence Are Related to Glutamate Metabolism and Glial Function in the Anterior Cingulate Cortex: A H-Magnetic Resonance Spectroscopy Study.
Watts J, Garani R, Silva T, Lalang N, Chavez S, Mizrahi R
Front Psychiatry. 2020; 11:764.
PMID: 32973572
PMC: 7468488.
DOI: 10.3389/fpsyt.2020.00764.
Impact of Cannabis Use on Brain Structure and Function in Suppressed HIV Infection.
Kallianpur K, Birn R, Ndhlovu L, Souza S, Mitchell B, Paul R
J Behav Brain Sci. 2020; 10(8):344-370.
PMID: 32968547
PMC: 7508465.
How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings.
Navarri X, Afzali M, Lavoie J, Sinha R, Stein D, Momenan R
Hum Brain Mapp. 2020; 43(1):399-413.
PMID: 32643841
PMC: 8675406.
DOI: 10.1002/hbm.25114.
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.
Colizzi M, Ruggeri M, Bhattacharyya S
Front Psychol. 2020; 11:833.
PMID: 32528345
PMC: 7247841.
DOI: 10.3389/fpsyg.2020.00833.
A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations.
Blest-Hopley G, Giampietro V, Bhattacharyya S
Brain Sci. 2020; 10(2).
PMID: 32069958
PMC: 7071506.
DOI: 10.3390/brainsci10020102.
Recent cannabis use is associated with smaller hippocampus volume: High-resolution segmentation of structural subfields in a large non-clinical sample.
Owens M, Sweet L, MacKillop J
Addict Biol. 2020; 26(1):e12874.
PMID: 31991525
PMC: 9187039.
DOI: 10.1111/adb.12874.
Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review.
Sullivan E, Pfefferbaum A
Neuropsychology. 2019; 33(6):760-780.
PMID: 31448945
PMC: 7461729.
DOI: 10.1037/neu0000557.
Orbitofrontal cortex volume prospectively predicts cannabis and other substance use onset in adolescents.
Wade N, Bagot K, Cota C, Fotros A, Squeglia L, Meredith L
J Psychopharmacol. 2019; 33(9):1124-1131.
PMID: 31215833
PMC: 6864237.
DOI: 10.1177/0269881119855971.
Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies.
Lorenzetti V, Chye Y, Silva P, Solowij N, Roberts C
Eur Arch Psychiatry Clin Neurosci. 2019; 269(1):59-71.
PMID: 30706169
DOI: 10.1007/s00406-019-00979-1.
Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use.
Burggren A, Siddarth P, Mahmood Z, London E, Harrison T, Merrill D
Cannabis Cannabinoid Res. 2018; 3(1):242-251.
PMID: 30547094
PMC: 6290479.
DOI: 10.1089/can.2018.0035.
The neuropsychopharmacology of cannabis: A review of human imaging studies.
Bloomfield M, Hindocha C, Green S, Wall M, Lees R, Petrilli K
Pharmacol Ther. 2018; 195:132-161.
PMID: 30347211
PMC: 6416743.
DOI: 10.1016/j.pharmthera.2018.10.006.
Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.
Fischer B, Russell C, Rehm J, Leece P
J Public Health (Oxf). 2018; 41(2):412-421.
PMID: 29860521
PMC: 6636689.
DOI: 10.1093/pubmed/fdy090.